CLINICALLY PREDICTIVE MODULATION OF COGNITIVE IMPAIRMENTS IN MOUSE TOUCHSCREEN TASKS Article Swipe
Daisy L. Spark
,
Juulke Castelijn
,
Leonid Churilov
,
Trang Pham
,
Michelle A. Camerino
,
Christopher J. Langmead
,
Gregory D. Stewart
,
Jess Nithianantharajah
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1093/ijnp/pyae059.088
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1093/ijnp/pyae059.088
Background Cognitive deficits in individuals with schizophrenia present a significant barrier to maintaining interpersonal relationships, employment, and independent living. Moderate to severe impairments have been found in cognitive domains including working memory, attention, learning and executive function. Despite the clear impact on functional outcomes, there are currently no approved treatments for cognitive impairments associated with schizophrenia (CIAS). Extensive efforts to develop pro-cognitive medicines, both for CIAS and other neuropsychiatric disorders, have repeatedly led to clinical trials that do not reflect the efficacy predicted in preclinical models. Aims & Objectives The rodent touchscreen platform has begun to bridge the translational gap between preclinical and clinical assessments of cognitive function. However, to date there has been no pharmacological validation of whether these tests are stringent enough to be clinically predictive and can therefore improve translation of CIAS treatments. Method Here, we use an NMDA receptor antagonist mouse model (acute low-dose administration) that we have validated for cognitive deficits in working memory performance on the rodent trial-unique delayed nonmatch-to-location touchscreen task. We then measured the effect of 1) current standard of care (aripiprazole and olanzapine), 2) failed investigational new drugs (IND) for CIAS (atomoxetine and encenicline), and 3) a current IND for schizophrenia (xanomeline) on working memory and attentional impairments. Results For the first time, we demonstrate a translational method for cognitive assessment in mice that can distinguish drugs with clinical efficacy from those without. Discussion & Conclusion These results provide critical insight into the predictive validity of our preclinical assay and cognitive deficit model, and have significant implications for the development and translation of novel pro-cognitive medicines.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1093/ijnp/pyae059.088
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4407387101
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4407387101Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1093/ijnp/pyae059.088Digital Object Identifier
- Title
-
CLINICALLY PREDICTIVE MODULATION OF COGNITIVE IMPAIRMENTS IN MOUSE TOUCHSCREEN TASKSWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-02-01Full publication date if available
- Authors
-
Daisy L. Spark, Juulke Castelijn, Leonid Churilov, Trang Pham, Michelle A. Camerino, Christopher J. Langmead, Gregory D. Stewart, Jess NithianantharajahList of authors in order
- Landing page
-
https://doi.org/10.1093/ijnp/pyae059.088Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1093/ijnp/pyae059.088Direct OA link when available
- Concepts
-
Touchscreen, Cognition, Modulation (music), Neuroscience, Psychology, Physical medicine and rehabilitation, Medicine, Computer science, Cognitive psychology, Human–computer interaction, Physics, AcousticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4407387101 |
|---|---|
| doi | https://doi.org/10.1093/ijnp/pyae059.088 |
| ids.doi | https://doi.org/10.1093/ijnp/pyae059.088 |
| ids.openalex | https://openalex.org/W4407387101 |
| fwci | 0.0 |
| type | article |
| title | CLINICALLY PREDICTIVE MODULATION OF COGNITIVE IMPAIRMENTS IN MOUSE TOUCHSCREEN TASKS |
| biblio.issue | Supplement_1 |
| biblio.volume | 28 |
| biblio.last_page | i50 |
| biblio.first_page | i50 |
| topics[0].id | https://openalex.org/T11079 |
| topics[0].field.id | https://openalex.org/fields/32 |
| topics[0].field.display_name | Psychology |
| topics[0].score | 0.6535999774932861 |
| topics[0].domain.id | https://openalex.org/domains/2 |
| topics[0].domain.display_name | Social Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/3205 |
| topics[0].subfield.display_name | Experimental and Cognitive Psychology |
| topics[0].display_name | Creativity in Education and Neuroscience |
| is_xpac | False |
| apc_list.value | 1945 |
| apc_list.currency | GBP |
| apc_list.value_usd | 2385 |
| apc_paid.value | 1945 |
| apc_paid.currency | GBP |
| apc_paid.value_usd | 2385 |
| concepts[0].id | https://openalex.org/C2778539339 |
| concepts[0].level | 2 |
| concepts[0].score | 0.9563722610473633 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q165970 |
| concepts[0].display_name | Touchscreen |
| concepts[1].id | https://openalex.org/C169900460 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5851141214370728 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q2200417 |
| concepts[1].display_name | Cognition |
| concepts[2].id | https://openalex.org/C123079801 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5324267745018005 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q750240 |
| concepts[2].display_name | Modulation (music) |
| concepts[3].id | https://openalex.org/C169760540 |
| concepts[3].level | 1 |
| concepts[3].score | 0.5300913453102112 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q207011 |
| concepts[3].display_name | Neuroscience |
| concepts[4].id | https://openalex.org/C15744967 |
| concepts[4].level | 0 |
| concepts[4].score | 0.4453669786453247 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q9418 |
| concepts[4].display_name | Psychology |
| concepts[5].id | https://openalex.org/C99508421 |
| concepts[5].level | 1 |
| concepts[5].score | 0.43686461448669434 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2678675 |
| concepts[5].display_name | Physical medicine and rehabilitation |
| concepts[6].id | https://openalex.org/C71924100 |
| concepts[6].level | 0 |
| concepts[6].score | 0.36177247762680054 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[6].display_name | Medicine |
| concepts[7].id | https://openalex.org/C41008148 |
| concepts[7].level | 0 |
| concepts[7].score | 0.36144620180130005 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q21198 |
| concepts[7].display_name | Computer science |
| concepts[8].id | https://openalex.org/C180747234 |
| concepts[8].level | 1 |
| concepts[8].score | 0.33634811639785767 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q23373 |
| concepts[8].display_name | Cognitive psychology |
| concepts[9].id | https://openalex.org/C107457646 |
| concepts[9].level | 1 |
| concepts[9].score | 0.23401889204978943 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q207434 |
| concepts[9].display_name | Human–computer interaction |
| concepts[10].id | https://openalex.org/C121332964 |
| concepts[10].level | 0 |
| concepts[10].score | 0.06386813521385193 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q413 |
| concepts[10].display_name | Physics |
| concepts[11].id | https://openalex.org/C24890656 |
| concepts[11].level | 1 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q82811 |
| concepts[11].display_name | Acoustics |
| keywords[0].id | https://openalex.org/keywords/touchscreen |
| keywords[0].score | 0.9563722610473633 |
| keywords[0].display_name | Touchscreen |
| keywords[1].id | https://openalex.org/keywords/cognition |
| keywords[1].score | 0.5851141214370728 |
| keywords[1].display_name | Cognition |
| keywords[2].id | https://openalex.org/keywords/modulation |
| keywords[2].score | 0.5324267745018005 |
| keywords[2].display_name | Modulation (music) |
| keywords[3].id | https://openalex.org/keywords/neuroscience |
| keywords[3].score | 0.5300913453102112 |
| keywords[3].display_name | Neuroscience |
| keywords[4].id | https://openalex.org/keywords/psychology |
| keywords[4].score | 0.4453669786453247 |
| keywords[4].display_name | Psychology |
| keywords[5].id | https://openalex.org/keywords/physical-medicine-and-rehabilitation |
| keywords[5].score | 0.43686461448669434 |
| keywords[5].display_name | Physical medicine and rehabilitation |
| keywords[6].id | https://openalex.org/keywords/medicine |
| keywords[6].score | 0.36177247762680054 |
| keywords[6].display_name | Medicine |
| keywords[7].id | https://openalex.org/keywords/computer-science |
| keywords[7].score | 0.36144620180130005 |
| keywords[7].display_name | Computer science |
| keywords[8].id | https://openalex.org/keywords/cognitive-psychology |
| keywords[8].score | 0.33634811639785767 |
| keywords[8].display_name | Cognitive psychology |
| keywords[9].id | https://openalex.org/keywords/human–computer-interaction |
| keywords[9].score | 0.23401889204978943 |
| keywords[9].display_name | Human–computer interaction |
| keywords[10].id | https://openalex.org/keywords/physics |
| keywords[10].score | 0.06386813521385193 |
| keywords[10].display_name | Physics |
| language | en |
| locations[0].id | doi:10.1093/ijnp/pyae059.088 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S199972112 |
| locations[0].source.issn | 1461-1457, 1469-5111 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 1461-1457 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | The International Journal of Neuropsychopharmacology |
| locations[0].source.host_organization | https://openalex.org/P4310311647 |
| locations[0].source.host_organization_name | University of Oxford |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310311647 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | International Journal of Neuropsychopharmacology |
| locations[0].landing_page_url | https://doi.org/10.1093/ijnp/pyae059.088 |
| locations[1].id | pmh:oai:pubmedcentral.nih.gov:11814675 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S2764455111 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed Central |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | other-oa |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/other-oa |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Int J Neuropsychopharmacol |
| locations[1].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/11814675 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5020517626 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-5120-8405 |
| authorships[0].author.display_name | Daisy L. Spark |
| authorships[0].countries | AU |
| authorships[0].affiliations[0].raw_affiliation_string | Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I242743682 |
| authorships[0].affiliations[1].raw_affiliation_string | The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia |
| authorships[0].institutions[0].id | https://openalex.org/I242743682 |
| authorships[0].institutions[0].ror | https://ror.org/03a2tac74 |
| authorships[0].institutions[0].type | facility |
| authorships[0].institutions[0].lineage | https://openalex.org/I165779595, https://openalex.org/I242743682 |
| authorships[0].institutions[0].country_code | AU |
| authorships[0].institutions[0].display_name | Florey Institute of Neuroscience and Mental Health |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | *Daisy Spark |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Phrenix Therapeutics, Parkville, Victoria, Australia, The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia |
| authorships[1].author.id | https://openalex.org/A5116236132 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Juulke Castelijn |
| authorships[1].countries | AU |
| authorships[1].affiliations[0].raw_affiliation_string | Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I242743682 |
| authorships[1].affiliations[1].raw_affiliation_string | The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia |
| authorships[1].institutions[0].id | https://openalex.org/I242743682 |
| authorships[1].institutions[0].ror | https://ror.org/03a2tac74 |
| authorships[1].institutions[0].type | facility |
| authorships[1].institutions[0].lineage | https://openalex.org/I165779595, https://openalex.org/I242743682 |
| authorships[1].institutions[0].country_code | AU |
| authorships[1].institutions[0].display_name | Florey Institute of Neuroscience and Mental Health |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Juulke Castelijn |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Phrenix Therapeutics, Parkville, Victoria, Australia, The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia |
| authorships[2].author.id | https://openalex.org/A5015105927 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-9807-6606 |
| authorships[2].author.display_name | Leonid Churilov |
| authorships[2].countries | AU |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I165779595 |
| authorships[2].affiliations[0].raw_affiliation_string | Melbourne Medical School, The University of Melbourne, Parkville, Victoria, Australia |
| authorships[2].institutions[0].id | https://openalex.org/I165779595 |
| authorships[2].institutions[0].ror | https://ror.org/01ej9dk98 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I165779595 |
| authorships[2].institutions[0].country_code | AU |
| authorships[2].institutions[0].display_name | The University of Melbourne |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Leonid Churilov |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Melbourne Medical School, The University of Melbourne, Parkville, Victoria, Australia |
| authorships[3].author.id | https://openalex.org/A5022353474 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7081-2640 |
| authorships[3].author.display_name | Trang Pham |
| authorships[3].countries | AU |
| authorships[3].affiliations[0].raw_affiliation_string | Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I56590836 |
| authorships[3].affiliations[1].raw_affiliation_string | Australian Translational Medicinal Chemistry Facility, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia |
| authorships[3].institutions[0].id | https://openalex.org/I56590836 |
| authorships[3].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[3].institutions[0].country_code | AU |
| authorships[3].institutions[0].display_name | Monash University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Trang Pham |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Australian Translational Medicinal Chemistry Facility, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[4].author.id | https://openalex.org/A5027011296 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-3352-3882 |
| authorships[4].author.display_name | Michelle A. Camerino |
| authorships[4].countries | AU |
| authorships[4].affiliations[0].raw_affiliation_string | Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I56590836 |
| authorships[4].affiliations[1].raw_affiliation_string | Australian Translational Medicinal Chemistry Facility, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia |
| authorships[4].institutions[0].id | https://openalex.org/I56590836 |
| authorships[4].institutions[0].ror | https://ror.org/02bfwt286 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I56590836 |
| authorships[4].institutions[0].country_code | AU |
| authorships[4].institutions[0].display_name | Monash University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Michelle Camerino |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Australian Translational Medicinal Chemistry Facility, Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[5].author.id | https://openalex.org/A5039200272 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-3483-1120 |
| authorships[5].author.display_name | Christopher J. Langmead |
| authorships[5].countries | AU |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I2801350665, https://openalex.org/I56590836 |
| authorships[5].affiliations[0].raw_affiliation_string | Neuromedicines Discovery Centre, Monash University, Parkville, Victoria, Australia |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I56590836 |
| authorships[5].affiliations[1].raw_affiliation_string | Drug Discovery Biology, Neuroscience &Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia |
| authorships[5].affiliations[2].raw_affiliation_string | Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[5].institutions[0].id | https://openalex.org/I2801350665 |
| authorships[5].institutions[0].ror | https://ror.org/036s9kg65 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2801350665, https://openalex.org/I4210121067 |
| authorships[5].institutions[0].country_code | AU |
| authorships[5].institutions[0].display_name | Monash Medical Centre |
| authorships[5].institutions[1].id | https://openalex.org/I56590836 |
| authorships[5].institutions[1].ror | https://ror.org/02bfwt286 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I56590836 |
| authorships[5].institutions[1].country_code | AU |
| authorships[5].institutions[1].display_name | Monash University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Christopher J Langmead |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Drug Discovery Biology, Neuroscience &Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, Neuromedicines Discovery Centre, Monash University, Parkville, Victoria, Australia, Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[6].author.id | https://openalex.org/A5027651155 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9748-4990 |
| authorships[6].author.display_name | Gregory D. Stewart |
| authorships[6].countries | AU |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2801350665, https://openalex.org/I56590836 |
| authorships[6].affiliations[0].raw_affiliation_string | Neuromedicines Discovery Centre, Monash University, Parkville, Victoria, Australia |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I56590836 |
| authorships[6].affiliations[1].raw_affiliation_string | Drug Discovery Biology, Neuroscience &Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia |
| authorships[6].affiliations[2].raw_affiliation_string | Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[6].institutions[0].id | https://openalex.org/I2801350665 |
| authorships[6].institutions[0].ror | https://ror.org/036s9kg65 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2801350665, https://openalex.org/I4210121067 |
| authorships[6].institutions[0].country_code | AU |
| authorships[6].institutions[0].display_name | Monash Medical Centre |
| authorships[6].institutions[1].id | https://openalex.org/I56590836 |
| authorships[6].institutions[1].ror | https://ror.org/02bfwt286 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I56590836 |
| authorships[6].institutions[1].country_code | AU |
| authorships[6].institutions[1].display_name | Monash University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Gregory D Stewart |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Drug Discovery Biology, Neuroscience &Mental Health Therapeutic Program Area, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia, Neuromedicines Discovery Centre, Monash University, Parkville, Victoria, Australia, Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[7].author.id | https://openalex.org/A5074495455 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-3501-1143 |
| authorships[7].author.display_name | Jess Nithianantharajah |
| authorships[7].countries | AU |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I242743682 |
| authorships[7].affiliations[0].raw_affiliation_string | The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia |
| authorships[7].affiliations[1].raw_affiliation_string | Phrenix Therapeutics, Parkville, Victoria, Australia |
| authorships[7].institutions[0].id | https://openalex.org/I242743682 |
| authorships[7].institutions[0].ror | https://ror.org/03a2tac74 |
| authorships[7].institutions[0].type | facility |
| authorships[7].institutions[0].lineage | https://openalex.org/I165779595, https://openalex.org/I242743682 |
| authorships[7].institutions[0].country_code | AU |
| authorships[7].institutions[0].display_name | Florey Institute of Neuroscience and Mental Health |
| authorships[7].author_position | last |
| authorships[7].raw_author_name | Jess Nithianantharajah |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Phrenix Therapeutics, Parkville, Victoria, Australia, The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1093/ijnp/pyae059.088 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | CLINICALLY PREDICTIVE MODULATION OF COGNITIVE IMPAIRMENTS IN MOUSE TOUCHSCREEN TASKS |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11079 |
| primary_topic.field.id | https://openalex.org/fields/32 |
| primary_topic.field.display_name | Psychology |
| primary_topic.score | 0.6535999774932861 |
| primary_topic.domain.id | https://openalex.org/domains/2 |
| primary_topic.domain.display_name | Social Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/3205 |
| primary_topic.subfield.display_name | Experimental and Cognitive Psychology |
| primary_topic.display_name | Creativity in Education and Neuroscience |
| related_works | https://openalex.org/W2362245340, https://openalex.org/W2016136991, https://openalex.org/W2611740235, https://openalex.org/W3183694079, https://openalex.org/W2548919583, https://openalex.org/W427448412, https://openalex.org/W4366547564, https://openalex.org/W2889992002, https://openalex.org/W2179864129, https://openalex.org/W2903682636 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1093/ijnp/pyae059.088 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S199972112 |
| best_oa_location.source.issn | 1461-1457, 1469-5111 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 1461-1457 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | The International Journal of Neuropsychopharmacology |
| best_oa_location.source.host_organization | https://openalex.org/P4310311647 |
| best_oa_location.source.host_organization_name | University of Oxford |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310311647 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | International Journal of Neuropsychopharmacology |
| best_oa_location.landing_page_url | https://doi.org/10.1093/ijnp/pyae059.088 |
| primary_location.id | doi:10.1093/ijnp/pyae059.088 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S199972112 |
| primary_location.source.issn | 1461-1457, 1469-5111 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 1461-1457 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | The International Journal of Neuropsychopharmacology |
| primary_location.source.host_organization | https://openalex.org/P4310311647 |
| primary_location.source.host_organization_name | University of Oxford |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310311647 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | International Journal of Neuropsychopharmacology |
| primary_location.landing_page_url | https://doi.org/10.1093/ijnp/pyae059.088 |
| publication_date | 2025-02-01 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.a | 9, 196, 215 |
| abstract_inverted_index.1) | 175 |
| abstract_inverted_index.2) | 183 |
| abstract_inverted_index.3) | 195 |
| abstract_inverted_index.We | 169 |
| abstract_inverted_index.an | 141 |
| abstract_inverted_index.be | 126 |
| abstract_inverted_index.do | 78 |
| abstract_inverted_index.in | 4, 27, 84, 157, 221 |
| abstract_inverted_index.no | 48, 115 |
| abstract_inverted_index.of | 106, 118, 134, 174, 178, 245, 262 |
| abstract_inverted_index.on | 42, 161, 202 |
| abstract_inverted_index.to | 12, 21, 60, 74, 96, 110, 125 |
| abstract_inverted_index.we | 139, 151, 213 |
| abstract_inverted_index.For | 209 |
| abstract_inverted_index.IND | 198 |
| abstract_inverted_index.The | 90 |
| abstract_inverted_index.and | 17, 35, 67, 103, 129, 181, 192, 194, 205, 249, 253, 260 |
| abstract_inverted_index.are | 46, 122 |
| abstract_inverted_index.can | 130, 224 |
| abstract_inverted_index.for | 51, 65, 154, 189, 199, 218, 257 |
| abstract_inverted_index.gap | 100 |
| abstract_inverted_index.has | 94, 113 |
| abstract_inverted_index.led | 73 |
| abstract_inverted_index.new | 186 |
| abstract_inverted_index.not | 79 |
| abstract_inverted_index.our | 246 |
| abstract_inverted_index.the | 39, 81, 98, 162, 172, 210, 242, 258 |
| abstract_inverted_index.use | 140 |
| abstract_inverted_index.Aims | 87 |
| abstract_inverted_index.CIAS | 66, 135, 190 |
| abstract_inverted_index.NMDA | 142 |
| abstract_inverted_index.been | 25, 114 |
| abstract_inverted_index.both | 64 |
| abstract_inverted_index.care | 179 |
| abstract_inverted_index.date | 111 |
| abstract_inverted_index.from | 230 |
| abstract_inverted_index.have | 24, 71, 152, 254 |
| abstract_inverted_index.into | 241 |
| abstract_inverted_index.mice | 222 |
| abstract_inverted_index.that | 77, 150, 223 |
| abstract_inverted_index.then | 170 |
| abstract_inverted_index.with | 6, 55, 227 |
| abstract_inverted_index.& | 88, 234 |
| abstract_inverted_index.(IND) | 188 |
| abstract_inverted_index.Here, | 138 |
| abstract_inverted_index.These | 236 |
| abstract_inverted_index.assay | 248 |
| abstract_inverted_index.begun | 95 |
| abstract_inverted_index.clear | 40 |
| abstract_inverted_index.drugs | 187, 226 |
| abstract_inverted_index.first | 211 |
| abstract_inverted_index.found | 26 |
| abstract_inverted_index.model | 146 |
| abstract_inverted_index.mouse | 145 |
| abstract_inverted_index.novel | 263 |
| abstract_inverted_index.other | 68 |
| abstract_inverted_index.task. | 168 |
| abstract_inverted_index.tests | 121 |
| abstract_inverted_index.there | 45, 112 |
| abstract_inverted_index.these | 120 |
| abstract_inverted_index.those | 231 |
| abstract_inverted_index.time, | 212 |
| abstract_inverted_index.(acute | 147 |
| abstract_inverted_index.Method | 137 |
| abstract_inverted_index.bridge | 97 |
| abstract_inverted_index.effect | 173 |
| abstract_inverted_index.enough | 124 |
| abstract_inverted_index.failed | 184 |
| abstract_inverted_index.impact | 41 |
| abstract_inverted_index.memory | 159, 204 |
| abstract_inverted_index.method | 217 |
| abstract_inverted_index.model, | 252 |
| abstract_inverted_index.rodent | 91, 163 |
| abstract_inverted_index.severe | 22 |
| abstract_inverted_index.trials | 76 |
| abstract_inverted_index.(CIAS). | 57 |
| abstract_inverted_index.Despite | 38 |
| abstract_inverted_index.Results | 208 |
| abstract_inverted_index.barrier | 11 |
| abstract_inverted_index.between | 101 |
| abstract_inverted_index.current | 176, 197 |
| abstract_inverted_index.deficit | 251 |
| abstract_inverted_index.delayed | 165 |
| abstract_inverted_index.develop | 61 |
| abstract_inverted_index.domains | 29 |
| abstract_inverted_index.efforts | 59 |
| abstract_inverted_index.improve | 132 |
| abstract_inverted_index.insight | 240 |
| abstract_inverted_index.living. | 19 |
| abstract_inverted_index.memory, | 32 |
| abstract_inverted_index.models. | 86 |
| abstract_inverted_index.present | 8 |
| abstract_inverted_index.provide | 238 |
| abstract_inverted_index.reflect | 80 |
| abstract_inverted_index.results | 237 |
| abstract_inverted_index.whether | 119 |
| abstract_inverted_index.working | 31, 158, 203 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.However, | 109 |
| abstract_inverted_index.Moderate | 20 |
| abstract_inverted_index.approved | 49 |
| abstract_inverted_index.clinical | 75, 104, 228 |
| abstract_inverted_index.critical | 239 |
| abstract_inverted_index.deficits | 3, 156 |
| abstract_inverted_index.efficacy | 82, 229 |
| abstract_inverted_index.learning | 34 |
| abstract_inverted_index.low-dose | 148 |
| abstract_inverted_index.measured | 171 |
| abstract_inverted_index.platform | 93 |
| abstract_inverted_index.receptor | 143 |
| abstract_inverted_index.standard | 177 |
| abstract_inverted_index.validity | 244 |
| abstract_inverted_index.without. | 232 |
| abstract_inverted_index.Cognitive | 2 |
| abstract_inverted_index.Extensive | 58 |
| abstract_inverted_index.cognitive | 28, 52, 107, 155, 219, 250 |
| abstract_inverted_index.currently | 47 |
| abstract_inverted_index.executive | 36 |
| abstract_inverted_index.function. | 37, 108 |
| abstract_inverted_index.including | 30 |
| abstract_inverted_index.outcomes, | 44 |
| abstract_inverted_index.predicted | 83 |
| abstract_inverted_index.stringent | 123 |
| abstract_inverted_index.therefore | 131 |
| abstract_inverted_index.validated | 153 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 235 |
| abstract_inverted_index.Discussion | 233 |
| abstract_inverted_index.Objectives | 89 |
| abstract_inverted_index.antagonist | 144 |
| abstract_inverted_index.assessment | 220 |
| abstract_inverted_index.associated | 54 |
| abstract_inverted_index.attention, | 33 |
| abstract_inverted_index.clinically | 127 |
| abstract_inverted_index.disorders, | 70 |
| abstract_inverted_index.functional | 43 |
| abstract_inverted_index.medicines, | 63 |
| abstract_inverted_index.medicines. | 265 |
| abstract_inverted_index.predictive | 128, 243 |
| abstract_inverted_index.repeatedly | 72 |
| abstract_inverted_index.treatments | 50 |
| abstract_inverted_index.validation | 117 |
| abstract_inverted_index.assessments | 105 |
| abstract_inverted_index.attentional | 206 |
| abstract_inverted_index.demonstrate | 214 |
| abstract_inverted_index.development | 259 |
| abstract_inverted_index.distinguish | 225 |
| abstract_inverted_index.employment, | 16 |
| abstract_inverted_index.impairments | 23, 53 |
| abstract_inverted_index.independent | 18 |
| abstract_inverted_index.individuals | 5 |
| abstract_inverted_index.maintaining | 13 |
| abstract_inverted_index.performance | 160 |
| abstract_inverted_index.preclinical | 85, 102, 247 |
| abstract_inverted_index.significant | 10, 255 |
| abstract_inverted_index.touchscreen | 92, 167 |
| abstract_inverted_index.translation | 133, 261 |
| abstract_inverted_index.treatments. | 136 |
| abstract_inverted_index.(atomoxetine | 191 |
| abstract_inverted_index.(xanomeline) | 201 |
| abstract_inverted_index.impairments. | 207 |
| abstract_inverted_index.implications | 256 |
| abstract_inverted_index.olanzapine), | 182 |
| abstract_inverted_index.trial-unique | 164 |
| abstract_inverted_index.(aripiprazole | 180 |
| abstract_inverted_index.encenicline), | 193 |
| abstract_inverted_index.interpersonal | 14 |
| abstract_inverted_index.pro-cognitive | 62, 264 |
| abstract_inverted_index.schizophrenia | 7, 56, 200 |
| abstract_inverted_index.translational | 99, 216 |
| abstract_inverted_index.relationships, | 15 |
| abstract_inverted_index.administration) | 149 |
| abstract_inverted_index.investigational | 185 |
| abstract_inverted_index.pharmacological | 116 |
| abstract_inverted_index.neuropsychiatric | 69 |
| abstract_inverted_index.nonmatch-to-location | 166 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 8 |
| citation_normalized_percentile.value | 0.04587342 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | True |